A detailed history of Vontobel Holding Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 13,643 shares of ADMA stock, worth $259,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,643
Previous 12,755 6.96%
Holding current value
$259,762
Previous $142,000 91.55%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$11.21 - $20.03 $9,954 - $17,786
888 Added 6.96%
13,643 $272,000
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $76,274 - $142,600
12,755 New
12,755 $142,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.74B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.